Core Laboratories
CLB
176 hedge funds and large institutions have $905M invested in Core Laboratories in 2022 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 58 increasing their positions, 66 reducing their positions, and 35 closing their positions.
122% more call options, than puts
Call options by funds: $2M | Put options by funds: $899K
1.53% more ownership
Funds ownership: 97.11% → 98.64% (+1.5%)
10% less funds holding
Funds holding: 196 → 176 (-20)
12% less repeat investments, than reductions
Existing positions increased: 58 | Existing positions reduced: 66
36% less capital invested
Capital invested by funds: $1.42B → $905M (-$515M)
40% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 35
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BTW
Boston Trust Walden
Boston,
Massachusetts
|
+$53M |
| 2 |
AI
Ariel Investments
Chicago,
Illinois
|
+$26.2M |
| 3 |
WI
Wintrust Investments
Chicago,
Illinois
|
+$4.87M |
| 4 |
BlackRock
New York
|
+$4.07M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$2.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CPH
C Partners Holding
Zurich,
Switzerland
|
-$23.2M |
| 2 |
Fisher Asset Management
Camas,
Washington
|
-$17.9M |
| 3 |
SCA
Southpoint Capital Advisors
New York
|
-$5.96M |
| 4 |
FAM
Fred Alger Management
New York
|
-$5.48M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$5.26M |
CLB Hedge Fund Activity: Q2 2022 in Review
176 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Core Laboratories (CLB) for Q2 2022, worth a combined $905M — down 36% from $1.42B a quarter earlier.
Sellers outnumbered buyers: 35 funds closed out of CLB and 21 opened new positions — a net loss of 14 holders — while 66 trimmed existing stakes and 58 added.
The largest buyer was Boston Trust Walden, opening a new position worth an estimated $53M. The largest seller was C Partners Holding, exiting entirely with an estimated $23.2M sold.
- 176 institutional investors held Core Laboratories (CLB) as of Q2 2022, down from 196 in Q1 2022.
- Funds reported $905M of Core Laboratories stock for Q2 2022, down 36% quarter-over-quarter.
- 21 funds opened new Core Laboratories positions in Q2 2022 and 35 closed out, a net change of -14 holders.
- The largest Core Laboratories buyer in Q2 2022 was Boston Trust Walden, an estimated $53M added.
- The largest Core Laboratories seller in Q2 2022 was C Partners Holding, an estimated $23.2M sold.
Based on aggregated 13F filings for Q2 2022.